Phlexglobal Names John McNeill as CEO

Share Article

Rick Riegel, CEO moves to new role as Vice-Chairman of the Phlexglobal Board of Directors.

News Image
“The opportunity ahead for Phlexglobal is significant, and I look forward to accelerating the company’s growth trajectory and market leadership.” -John McNeil, CEO Phlexglobal

Phlexglobal today announced that its Board of Directors has appointed John McNeill as Chief Executive Officer and member of the Board of Directors effective January 14, 2019. McNeill previously held the position of President at Sparta Systems, Inc.

“John McNeill is ideally placed to lead Phlexglobal,” said former CEO Rick Riegel. “John is a proven life sciences industry veteran with demonstrated leadership, customer focus, product understanding and results. His vision for success will greatly benefit Phlexglobal as the company enters its next stage of further innovation and growth.” In addition to the appointment of John McNeill as CEO, Phlexglobal also announced that Rick Riegel has moved to the position of Vice-Chairman.

Prior to joining Phlexglobal, McNeill was a key member of the executive team at Sparta Systems for 7 years, helping to build out Sparta’s market leading and global solution for quality management systems for the life sciences and other regulated industries. During his tenure, Sparta increased market share and successfully transitioned to a cloud-based SaaS business model. Prior to Sparta, John held leadership positions at IRI, BravoSolution, and VerticalNet.

“Phlexglobal has an impressive leadership team, organization, customer commitment to success and is one of the few companies to have truly been recognized as the experts in the world through market leading technology and technology-enabled services. I am excited about joining such a talented and successful organization,” McNeill said. “The opportunity ahead for Phlexglobal is significant, and I look forward to accelerating the company’s growth trajectory and market leadership.”

“I’m impressed with John’s ability to successfully grow organizations, along with his talented leadership and relationships within the Life Sciences industry. John is a respected executive leader and with a keen focus on customer success and relationships,” said Steve Kent, Phlexglobal Chairman of the Board of Directors. Steve further commented, “I would also like to thank Rick for his significant contributions as CEO and now look forward to working with Rick as Vice-Chairman of the Board.”

About Phlexglobal
Phlexglobal provides the market-leading Trial Master File solution by leveraging dedicated and authoritative TMF technologies and expert services. The company offers a unique combination of sophisticated technology, clinical trial knowledge, regulatory understanding and document management skills to deliver a range of flexible, targeted solutions to meet business needs. At the conclusion of 2018, Phlexglobal had set new records in customer acquisition, revenue and EBITDA.

More information can be found at http://www.phlexglobal.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christopher D Englerth
Phlexglobal
+1 (215) 622-8798
Email >
Visit website